April 2016

C-Trials, the Israeli Association for Research and the Advancement of the Biomedical Community,  will hold the annual meeting of the clinical trials community in Israel on April 11, 2016, at the David Intercontinental Hotel in Tel Aviv. The event will bring together clinical researchers and professionals from the medical centers and industry in order to increase the effectiveness, safety and quality of clinical trials and strengthen the ethical and legislative
The Alon MedTech Ventures incubator is signing a cooperation agreement with Tsinghua University. Tsinghua University is considered one of China's leading universities. This is the first cooperation agreement of its kind between an Israeli technology incubator and a Chinese entity. The agreement is Tsinghua University's second in Israel, after it signed an agreement with Tel Aviv University in 2013 to establish a joint center in China for Israeli and Chinese researchers, called the XIN Research Center.
BioLineRx reports positive Phase II leukemia trial. The Jerusalem drug development company's share price is up 11% following the news. Israeli drug development company BiolineRX Ltd. (Nasdaq: BLRX); TASE:BLRX) has reported positive top-line results from BL-8040’s Phase II clinical trial in relapsed or refractory acute myeloid leukemia.
Emerald melanoma diagnosis system wins FDA approval. The system developed by Israeli company Emerald Medical Applications, formerly DermaCare, which is designed to diagnose melanoma, has been approved for marketing by the US Food and Drug Administration (FDA). Emerald's market cap is $10 million, following its merger with US stock exchange shell Zaxis in July 2015.
One in four life science innovations has Israeli roots, says expert. Annual biomed conference is Israel’s ‘calling card’ for medical professionals interested in the latest in life science technology. “Research in Israel is present in between 25% and 28% of the world’s successful biotech-based solutions,” according to Ruti Alon, a General Partner at Pitango Venture Capital. “Many of the patents in pharmaceuticals that are now being used to treat cancer, heart problems, and much more were developed at Israeli institutions like Hebrew University or the Weizmann Institute".
IATI-Biomed to hold 15th Israeli conference in May. Israel’s premier international biomed conference and exhibition, IATI-Biomed, will celebrate its 15th anniversary from May 24 to May 26, 2016, at the David InterContinental Hotel in Tel Aviv, Israel. Previous conferences have attracted over 6,000 participants from the Israeli and global life sciences industries. 
Now live! Our new translations division of high quality certified medical and pharmaceutical translations. You are welcome to visit our new webpage: www.qt-translations.com